Validation Study of a New Digital Treatment Test

Braingaze

Status: Unknown

Conditions: MCI; Alzheimer Disease

Treatments: Other: BGaze therapy Alzheimer

Study type: Interventional

Funder types: Industry

Identifiers

NCT04897464

BT-AD-01

Details and patient eligibility

About

Oculomotor behavior and cognitive processing of visual information are intimately connected. AD patients show ocular movement problems. Oculomotor deficits are broad consisting mainly of different saccade metrics, altered pupil responses. and smaller and irregular eye vergence movements. Here we test an interactive eye-tracking game to improve eye motion control and thereby training cognitive behavior

Enrollment: 60 estimated patients

Sex: All

Ages: 50 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Clinical diagnosis of MCI or AD

Exclusion criteria

1. Severe cognitive deterioration
2. History of neurological disease with clinically relevant impact on cognition
3. Severe psychiatric disorder
4. Incidental structural brain findings with impact on cognitive impairment
5. Presence of relevant visual problems

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

Treatment

Experimental group

Treatment:

Other: BGaze therapy Alzheimer